MHRA Drug Safety Update September 2022

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 2 September 2022) has been published and includes articles on:

  • Methylphenidate long-acting (modified-release) preparations: caution if switching between products due to differences in formulations
  • Rucaparib (Rubraca▼): withdrawal of third-line treatment indication
  • COVID-19 vaccines and medicines: updates for September 2022
  • Letters and medicine recalls sent to healthcare professionals in August 2022

To see the latest MHRA Drug Safety Updates in full, visit the website.

Discover how we are working to improve the outlook for community pharmacy at an event near you.

Click Here